medical sector

Serbia’s Pharmaceutical and Healthcare Sector: Growth Amid Regulatory Constraints

The pharmaceutical and healthcare sector in Serbia is developing into a hybrid model that integrates aspects of public infrastructure with export-oriented industry characteristics. According to the Q4 2025 report from the Serbian Chamber of Commerce (PKS), the sector demonstrates financial resilience and growth potential, but it faces challenges due to stringent pricing regulations, concentrated demand, and uneven access to capital. This environment presents a landscape that offers defensive investment opportunities while limiting scalability without significant structural reforms. At the macroeconomic…